Filed May 13, 2026Period of report May 12, 20260001468966-26-000004
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
PurchaseMay 12, 2026
Common Stock, par value $0.01 per share
1,618
$62.03
$100.36K
1,618
Indirect
Watkin Phoebe L. YangDirector
4
Filed May 11, 2026Period of report May 7, 20260001940538-26-000002
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
PurchaseMay 8, 2026
Common Stock, par value $0.01 per shareF3
1,000
$63.0063
$63.01K
13,702
Direct
William J StrombergDirector
4
Filed May 7, 2026Period of report May 6, 20260001352578-26-000004
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
PurchaseMay 6, 2026
Common Stock, par value $0.01 per share
1,000
$61.6892
$61.69K
15,330
Direct
H Lawrence Culp JRDirector
4
Filed May 7, 2026Period of report May 6, 20260001205247-26-000006
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
PurchaseMay 6, 2026
Common Stock, par value $0.01 per shareF1
80,805
$61.8783
$5.00M
151,207
Indirect
James SaccaroChief Financial Officer
4
Filed May 1, 2026Period of report May 1, 20260001593636-26-000008
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
PurchaseMay 1, 2026
Common Stock, par value $0.01 per shareF1
3,310
$60.5997
$200.59K
87,471
Frank R JimenezGC & Corporate Secretary
4
Filed Apr 30, 2026Period of report Apr 30, 20260001465175-26-000015
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
PurchaseApr 30, 2026
Common Stock, par value $0.01 per share
1,750
$60.45
$105.79K
93,932
Direct
Peter J ArduiniDirector · President and CEO
4
Filed Apr 30, 2026Period of report Apr 30, 20260001323134-26-000014
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
PurchaseApr 30, 2026
Common Stock, par value $0.01 per share
4,169
$59.925
$249.83K
259,424
Direct
P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.
F1Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.
F2Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
F3The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $62.97 to $63.01, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F1The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $61.50 to $62.22, inclusive. The Reporting Person undertakes to provide to GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F2Reflects the transfer by the reporting person of 37,091 shares of GE HealthCare common stock to a family trust on May 1, 2025.
F1The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $60.59 to $60.60, inclusive. The Reporting Person undertakes to provide to GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.